318 related articles for article (PubMed ID: 22771419)
1. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008.
Liao CH; Chuang CY; Huang YT; Lee PI; Hsueh PR
J Infect; 2012 Nov; 65(5):392-9. PubMed ID: 22771419
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics.
Lu PL; Hsueh PR; Hung CC; Chang SC; Luh KT; Lee CY
J Formos Med Assoc; 2000 Aug; 99(8):612-7. PubMed ID: 10969503
[TBL] [Abstract][Full Text] [Related]
3. Demographic and clinical characteristics of Campylobacter bacteremia in children with and without predisposing factors.
Ben-Shimol S; Carmi A; Greenberg D
Pediatr Infect Dis J; 2013 Nov; 32(11):e414-8. PubMed ID: 23694835
[TBL] [Abstract][Full Text] [Related]
4. [Incidence and susceptibility of Campylobacter jejuni in pediatric patients: involvement in bacteremia].
González-Abad MJ; Alonso-Sanz M
Rev Esp Quimioter; 2013 Jun; 26(2):92-6. PubMed ID: 23817644
[TBL] [Abstract][Full Text] [Related]
5. Campylobacter bacteraemia: 16 years of experience in a single centre.
Hussein K; Raz-Pasteur A; Shachor-Meyouhas Y; Geffen Y; Oren I; Paul M; Kassis I
Infect Dis (Lond); 2016; 48(11-12):796-9. PubMed ID: 27320494
[TBL] [Abstract][Full Text] [Related]
6. A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility.
Feodoroff B; Lauhio A; Ellström P; Rautelin H
Clin Infect Dis; 2011 Oct; 53(8):e99-e106. PubMed ID: 21921217
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008.
Valenza G; Frosch M; Abele-Horn M
Scand J Infect Dis; 2010; 42(1):57-60. PubMed ID: 20055727
[TBL] [Abstract][Full Text] [Related]
8. Clinical and microbiological characteristics of patients with bacteremia caused by Campylobacter species with an emphasis on the subspecies of C. fetus.
Liu YH; Yamazaki W; Huang YT; Liao CH; Sheng WH; Hsueh PR
J Microbiol Immunol Infect; 2019 Feb; 52(1):122-131. PubMed ID: 28801089
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.
Trajkovska-Dokic E; Mihajlov K; Mirchevska G; Kostovski M; Blazevska A; Stojkovska S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):73-80. PubMed ID: 31605592
[TBL] [Abstract][Full Text] [Related]
10. Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005.
Yang JR; Wu HS; Chiang CS; Mu JJ
BMC Infect Dis; 2008 Oct; 8():151. PubMed ID: 18973701
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
Gupta A; Nelson JM; Barrett TJ; Tauxe RV; Rossiter SP; Friedman CR; Joyce KW; Smith KE; Jones TF; Hawkins MA; Shiferaw B; Beebe JL; Vugia DJ; Rabatsky-Ehr T; Benson JA; Root TP; Angulo FJ;
Emerg Infect Dis; 2004 Jun; 10(6):1102-9. PubMed ID: 15207064
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter bacteremia in London: A 44-year single-center study.
O'Hara GA; Fitchett JRA; Klein JL
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):67-71. PubMed ID: 28629878
[TBL] [Abstract][Full Text] [Related]
13. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns.
Pigrau C; Bartolome R; Almirante B; Planes AM; Gavalda J; Pahissa A
Clin Infect Dis; 1997 Dec; 25(6):1414-20. PubMed ID: 9431389
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance profiles of Campylobacter species in the South Africa private health care sector.
Shobo CO; Bester LA; Baijnath S; Somboro AM; Peer AK; Essack SY
J Infect Dev Ctries; 2016 Nov; 10(11):1214-1221. PubMed ID: 27886034
[TBL] [Abstract][Full Text] [Related]
15. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors.
Nielsen H; Hansen KK; Gradel KO; Kristensen B; Ejlertsen T; Østergaard C; Schønheyder HC
Clin Microbiol Infect; 2010 Jan; 16(1):57-61. PubMed ID: 19673969
[TBL] [Abstract][Full Text] [Related]
16. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection.
Evans MR; Northey G; Sarvotham TS; Rigby CJ; Hopkins AL; Thomas DR
Clin Infect Dis; 2009 Jun; 48(11):1500-6. PubMed ID: 19400688
[TBL] [Abstract][Full Text] [Related]
17. A laboratory-based survey of Campylobacter infections in Prahova County.
Sorokin M; Usein CR; Irimia M; Damian M
Roum Arch Microbiol Immunol; 2007; 66(3-4):85-9. PubMed ID: 18928068
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Resistance in Campylobacter Species: Mechanisms and Genomic Epidemiology.
Whitehouse CA; Zhao S; Tate H
Adv Appl Microbiol; 2018; 103():1-47. PubMed ID: 29914655
[TBL] [Abstract][Full Text] [Related]
19. Relative contribution of target gene mutation and efflux to varying quinolone resistance in Irish Campylobacter isolates.
Corcoran D; Quinn T; Cotter L; Fanning S
FEMS Microbiol Lett; 2005 Dec; 253(1):39-46. PubMed ID: 16213669
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
Sonnevend Á; Kovács J; Pál T; Akawi N; Nagelkerke N; Schneider G
Scand J Infect Dis; 2011 Dec; 43(11-12):905-11. PubMed ID: 21905953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
